Jaime Guevara-Aguirre1, Arlan L Rosenbloom1, Priya Balasubramanian1, Enrique Teran1, Marco Guevara-Aguirre1, Carolina Guevara1, Patricio Procel1, Irene Alfaras1, Rafael De Cabo1, Stefano Di Biase1, Luis Narvaez1, Jannette Saavedra1, Valter D Longo1. 1. Universidad San Francisco de Quito (J.G.-A., E.T.), Quito, Ecuador; Instituto de Endocrinologia, Metabolismo y Repróduccion (J.G.-A., A.L.R., M.G.-A., C.G., P.P., L.N., J.S.), Quito Ecuador; University of Florida College of Medicine (A.L.R.), Gainesville, Florida 32608; Davis School of Gerontology (P.B., S.D.B., V.D.L.), University of Southern California, Los Angeles, California 90089; Experimental Gerontology Section (I.A., R.D.C.), Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224; and Longevity Institute (V.D.L.), University of Southern California, Los Angeles, California 90089.
Abstract
CONTEXT: Ecuadorian subjects with GH receptor deficiency (GHRD) have not developed diabetes, despite obesity. OBJECTIVE: We sought to determine the metabolic associations for this phenomenon. DESIGN: Four studies were carried out: 1) glucose, lipid, adipocytokine concentrations; 2) metabolomics evaluation; 3) metabolic responses to a high-calorie meal; and 4) oral glucose tolerance tests. SETTING: Clinical Research Institute in Quito, Ecuador. SUBJECTS: Adults homozygous for the E180 splice mutation of the GH receptor (GHRD) were matched for age, gender, and body mass index with unaffected control relatives (C) as follows: study 1, 27 GHRD and 35 C; study 2, 10 GHRD and 10 C; study 3, seven GHRD and 11 C; and study 4, seven GHRD and seven C. RESULTS: Although GHRD subjects had greater mean percentage body fat than controls, their fasting insulin, 2-hour blood glucose, and triglyceride levels were lower. The indicator of insulin sensitivity, homeostasis model of assessment 2%S, was greater (P < .0001), and the indicator of insulin resistance, homeostasis model of assessment 2-IR, was lower (P = .0025). Metabolomic differences between GHRD and control subjects were consistent with their differing insulin sensitivity, including postprandial decreases of branched-chain amino acids that were more pronounced in controls. High molecular weight and total adiponectin concentrations were greater in GHRD (P = .0004 and P = .0128, respectively), and leptin levels were lower (P = .02). Although approximately 65% the weight of controls, GHRD subjects consumed an identical high-calorie meal; nonetheless, their mean glucose concentrations were lower, with mean insulin levels one-third those of controls. Results of the 2-hour oral glucose tolerance test were similar. MAIN OUTCOME MEASURES: Measures of insulin sensitivity, adipocytokines, and energy metabolites. CONCLUSIONS: Without GH counter-regulation, GHRD is associated with insulin efficiency and obesity. Lower leptin levels, despite higher percentage body fat, suggest that obesity-associated leptin resistance is GH dependent. Elevated adiponectin levels not correlated with percentage body fat indicate that GH signaling is necessary for their typical suppression with obesity.
CONTEXT: Ecuadorian subjects with GH receptordeficiency (GHRD) have not developed diabetes, despite obesity. OBJECTIVE: We sought to determine the metabolic associations for this phenomenon. DESIGN: Four studies were carried out: 1) glucose, lipid, adipocytokine concentrations; 2) metabolomics evaluation; 3) metabolic responses to a high-calorie meal; and 4) oral glucose tolerance tests. SETTING: Clinical Research Institute in Quito, Ecuador. SUBJECTS: Adults homozygous for the E180 splice mutation of the GH receptor (GHRD) were matched for age, gender, and body mass index with unaffected control relatives (C) as follows: study 1, 27 GHRD and 35 C; study 2, 10 GHRD and 10 C; study 3, seven GHRD and 11 C; and study 4, seven GHRD and seven C. RESULTS: Although GHRD subjects had greater mean percentage body fat than controls, their fasting insulin, 2-hour blood glucose, and triglyceride levels were lower. The indicator of insulin sensitivity, homeostasis model of assessment 2%S, was greater (P < .0001), and the indicator of insulin resistance, homeostasis model of assessment 2-IR, was lower (P = .0025). Metabolomic differences between GHRD and control subjects were consistent with their differing insulin sensitivity, including postprandial decreases of branched-chain amino acids that were more pronounced in controls. High molecular weight and total adiponectin concentrations were greater in GHRD (P = .0004 and P = .0128, respectively), and leptin levels were lower (P = .02). Although approximately 65% the weight of controls, GHRD subjects consumed an identical high-calorie meal; nonetheless, their mean glucose concentrations were lower, with mean insulin levels one-third those of controls. Results of the 2-hour oral glucose tolerance test were similar. MAIN OUTCOME MEASURES: Measures of insulin sensitivity, adipocytokines, and energy metabolites. CONCLUSIONS: Without GH counter-regulation, GHRD is associated with insulin efficiency and obesity. Lower leptin levels, despite higher percentage body fat, suggest that obesity-associated leptin resistance is GH dependent. Elevated adiponectin levels not correlated with percentage body fat indicate that GH signaling is necessary for their typical suppression with obesity.
Authors: Geoffrey A Walford; Jaclyn Davis; A Sofia Warner; Rachel J Ackerman; Liana K Billings; Bindu Chamarthi; Rebecca R Fanelli; Alicia M Hernandez; Chunmei Huang; Sabina Q Khan; Katherine R Littleton; Janet Lo; Rita M McCarthy; Eugene P Rhee; Amy Deik; Elliot Stolerman; Andrew Taylor; Margo S Hudson; Thomas J Wang; David Altshuler; Richard W Grant; Clary B Clish; Robert E Gerszten; Jose C Florez Journal: Metabolism Date: 2013-08-15 Impact factor: 8.694
Authors: Andrea M Haqq; Michael J Muehlbauer; Christopher B Newgard; Steven Grambow; Michael Freemark Journal: J Clin Endocrinol Metab Date: 2010-10-20 Impact factor: 5.958
Authors: D A M Festen; A van Toorenenbergen; H J Duivenvoorden; A C S Hokken-Koelega Journal: J Clin Endocrinol Metab Date: 2007-01-30 Impact factor: 5.958
Authors: J Guevara-Aguirre; A L Rosenbloom; P J Fielder; F B Diamond; R G Rosenfeld Journal: J Clin Endocrinol Metab Date: 1993-02 Impact factor: 5.958
Authors: A P Goldstone; E L Thomas; A E Brynes; J D Bell; G Frost; N Saeed; J V Hajnal; J K Howard; A Holland; S R Bloom Journal: J Clin Endocrinol Metab Date: 2001-09 Impact factor: 5.958
Authors: Taísa A R Vicente; Ivina E S Rocha; Roberto Salvatori; Carla R P Oliveira; Rossana M C Pereira; Anita H O Souza; Viviane C Campos; Elenilde G Santos; Rachel D C Araújo Diniz; Eugênia H O Valença; Carlos C Epitácio-Pereira; Mario C P Oliveira; Andrea Mari; Manuel H Aguiar-Oliveira Journal: Endocr Connect Date: 2013-06-15 Impact factor: 3.335
Authors: Ele Ferrannini; Andrea Natali; Stefania Camastra; Monica Nannipieri; Andrea Mari; Klaus-Peter Adam; Michael V Milburn; Gabi Kastenmüller; Jerzy Adamski; Tiinamaija Tuomi; Valeriya Lyssenko; Leif Groop; Walter E Gall Journal: Diabetes Date: 2012-11-16 Impact factor: 9.461
Authors: Kevin C Corbit; João Paulo G Camporez; Jennifer L Tran; Camella G Wilson; Dylan A Lowe; Sarah M Nordstrom; Kirthana Ganeshan; Rachel J Perry; Gerald I Shulman; Michael J Jurczak; Ethan J Weiss Journal: JCI Insight Date: 2017-02-09
Authors: Kaoru Nashiro; Jaime Guevara-Aguirre; Meredith N Braskie; George W Hafzalla; Rico Velasco; Priya Balasubramanian; Min Wei; Paul M Thompson; Mara Mather; Marvin D Nelson; Alexandra Guevara; Enrique Teran; Valter D Longo Journal: J Neurosci Date: 2017-01-10 Impact factor: 6.167
Authors: Gabriela Colon; Tatiana Saccon; Augusto Schneider; Marcelo B Cavalcante; Derek M Huffman; Darlene Berryman; Ed List; Yuji Ikeno; Nicolas Musi; Andrzej Bartke; John Kopchick; James L Kirkland; Tamara Tchkonia; Michal M Masternak Journal: Geroscience Date: 2019-09-04 Impact factor: 7.713
Authors: Christelle Guillermier; Pouneh K Fazeli; Soomin Kim; Mingyue Lun; Jonah P Zuflacht; Jessica Milian; Hang Lee; Hugues Francois-Saint-Cyr; Francois Horreard; David Larson; Evan D Rosen; Richard T Lee; Claude P Lechene; Matthew L Steinhauser Journal: JCI Insight Date: 2017-03-09
Authors: Edward O List; Reetobrata Basu; Silvana Duran-Ortiz; Jackson Krejsa; Elizabeth A Jensen Journal: Rev Endocr Metab Disord Date: 2020-10-09 Impact factor: 6.514